Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial

Published:2018-07 Issue:7 Volume:19 Page:889-903
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cortes Jorge,Perl Alexander E,Döhner Hartmut,Kantarjian Hagop,Martinelli Giovanni,Kovacsovics Tibor,Rousselot Philippe,Steffen Björn,Dombret Hervé,Estey Elihu,Strickland Stephen,Altman Jessica K,Baldus Claudia D,Burnett Alan,Krämer Alwin,Russell Nigel,Shah Neil P,Smith Catherine C,Wang Eunice S,Ifrah Norbert,Gammon Guy,Trone Denise,Lazzaretto Deborah,Levis Mark

Publisher

Elsevier BV

Subject

Oncology

Reference39 articles.

1. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia;Patel;N Engl J Med,2012

2. FLT3: ITDoes matter in leukemia;Levis;Leukemia,2003

3. Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy;Boissel;Leukemia,2002

4. FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study;Whitman;Blood,2010

5. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?;Mrozek;Blood,2007

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment;Chinese Chemical Letters;2024-09

3. Quizartinib en association à la chimiothérapie pour les patients adultes atteints de leucémie aiguë myéloïde nouvellement diagnostiquée et positive pour le gène FLT3-ITD;Bulletin du Cancer;2024-09

4. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

5. Precision medicine in AML: overcoming resistance;International Journal of Hematology;2024-08-01